ECM
EDIT icon

Exchange Capital Management’s Editas Medicine EDIT Stock Holding History

Exchange Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-25
Closed -$1K – 236
2016
Q2 		$1K Buy
+25
New +$843 ﹤0.01% 230

Other funds holding EDIT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Exchange Capital Management's EDIT Position: Q3 2016 in Review

Exchange Capital Management sold out of Editas Medicine (EDIT) in Q3 2016, closing a stake of 25 shares — an estimated $1K sold.

Exchange Capital Management first reported a position in EDIT in Q2 2016 and held it in 1 quarter. The position peaked at $1K in Q2 2016. 75 funds tracked by Wall St. Rank hold EDIT as of Q3 2016.

  • Exchange Capital Management reported no remaining Editas Medicine position as of Q3 2016 after selling out during the quarter.
  • Exchange Capital Management sold 25 Editas Medicine shares in Q3 2016, an estimated $1K.
  • Exchange Capital Management first reported a position in Editas Medicine in Q2 2016 and held it in 1 quarter.
  • Exchange Capital Management's Editas Medicine position peaked at $1K in Q2 2016.
  • 75 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2016.

Based on Exchange Capital Management's 13F filing for Q3 2016, filed 9 Nov 2016.